Logo

BioCat to Distribute Kreatech s Labeling Tech in Germany, Switzerland, Austria

Sep 14, 2005

NEW YORK, Sept. 14 (GenomeWeb News) - Kreatech Biotechnology has signed up BioCat to distribute its molecular labeling technology in Germany, Switzerland, and Austria, the Amsterdam-based company said today.

 

Under the agreement, BioCat, located in Heidelberg, Germany, will supply Kreatech's Universal Linkage System, which allows users to attach a variety of labels to DNA, RNA, or proteins, to laboratories in Germany, Switzerland, and Austria.

 

Kreatech said it expects to expand its distribution network further in the next few month, both in Europe and Asia.

Breaking News
The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.